Related Experiment Video
Updated: Jun 4, 2026

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust
Published on: January 6, 2023
Case Report: Pulmonary alveolar proteinosis and fibrosis associated with indium-tin-oxide exposure
Xinyao Li1, Chuan Shi1, Qiaoling Chen1
1Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background:
Pulmonary alveolar proteinosis (PAP) is a rare respiratory disorder characterized by the excessive accumulation of surfactant material on alveolar surfaces and the dysfunction of alveolar macrophages. Indium-tin-oxide (ITO), a substance utilized in liquid crystal displays and solar panels, could be a potential cause of secondary PAP. Here, we report a rare case of interstitial lung disease in a solar panel processing worker with ITO exposure, which was pathologically confirmed as PAP and then progressed to pulmonary fibrosis.
Case Presentation:
A 35-year-old male was admitted with a symptom of dysponea. Chest computed tomography revealed diffuse, bilateral ground-glass opacities and interlobular septal thickening in both lungs. Transbronchial lung biopsy was PAS-positive, confirming the diagnosis of PAP. The indium levels in the patient's bronchoalveolar lavage fluid and plasma were far above the normal range. He underwent whole-lung lavage, but approximately 4 months later, he still developed progressive pulmonary fibrosis. Nintedanib showed no significant effect in slowing the decline of his lung function.
Conclusion:
When a patient has a definite history of indium exposure, the diagnosis of PAP should be considered. Workers need to wear protective measures daily, as lung diseases caused by ITO exposure are associated with a poor prognosis.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Chronic Obstructive Pulmonary Disease II: Emphysema

